SGS742

· Saegis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SGS742, covering 2009-12-11 to 2009-12-11. Get the full timeline:

Most recent: Clinical Trial Update: SGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD) [Phase 2]